Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Altis Labs announces today that it is leading an international coalition focused on the development and implementation of digital twins in clinical trials.
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]
This media release was originally published by Altis Labs on January 24, 2023. Toronto, Ontario – Altis Labs, Inc. (“Altis”), the computational imaging platform for advancing precision medicine, announces today an initiative focused on developing, validating, and commercializing fully automated imaging biomarkers for solid tumors using deep learning. Led by Altis, the initiative leverages a […]
Jan-2023
A trained opera singer with an accomplished business background and a professor of chemistry, renowned globally for his research and expertise, may not appear to have anything in common. Yet a shared passion for innovation, a desire to make a difference and the knowledge of an unmet need in medical treatment options, led Maria Antonakos […]
David Wilson founded Eye3concepts Inc. (Eye3) as a medical device company to address the unmet needs of the drug testing market. He recognized that the speed and sensitivity of existing drug tests were inadequate for the market, as the demand for rapid detection tests by employers and law enforcement personnel continues to grow. Eye3’s flagship […]